A Randomized Clinical Trial On Management Of Early Pregn
早期妊娠管理的随机临床试验
基本信息
- 批准号:7334099
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Background: Medical management with misoprostol for early pregnancy failure has been increasingly used. However, the efficacy, safety and acceptability of this treatment have yet to be established in a large randomized trial.
Methods: This multicenter trial randomized 652 women with a first trimester pregnancy failure (anembryonic gestation, fetal demise, incomplete and inevitable spontaneous abortion) to receive either vacuum aspiration (VA, standard of care) or 800 ig vaginal misoprostol in a 1:3 ratio. Subjects receiving misoprostol returned on Day 3. If the expulsion of POC was incomplete, a second dose of 800 ig vaginal misoprostol was given. On Day 8, if the expulsion was still incomplete, VA was offered. On Day 15, all subjects returned for follow-up visit. A telephone interview was conducted on Day 30. Failure was defined as VA (for the misoprostol treatment group) or reaspiration (for the VA group) for any reason within 30 days after the initial treatment. The study was powered to test whether the success rate in the misoprostol group was lower than that in the VA group by 18%. If the difference in success rate between the two groups did not exceed 18%, the treatments would be considered equivalent.
Results: Overall, 491 and 161 women, respectively, were randomized to medical or surgical management. Baseline characteristics of the two groups were comparable. In the misoprostol group, 71% of women had complete expulsion by day 3 and 85% by day 8. Overall, treatment failures occurred in 3% of the VA group and 15% of the misoprostol group (difference = 12%, 90% CI 9, 16%). Hemorrhage or endometritis that required hospitalization was rare (< 1%) and there were no differences between the two groups. Emergency hospital visit after the treatment occurred to 3.1% and 2.0% of women who received medical and surgical treatment, respectively (p = 0.59). 78% of women would choose misoprostol again and 83% recommend to others if needed. The acceptability was not different from that in the VA group.
Conclusion: Treatment of early pregnancy failure with 800 mg misoprostol per vagina is efficacious and safe with a success rate of around 85%. The risks for hemorrhage and endometritis are very low, and the side-effects are tolerable. It is an acceptable treatment to the majority of the participants.
背景:越来越多地使用了米索前列醇的医疗管理。但是,在大型随机试验中尚未确定这种治疗方法的功效,安全性和可接受性。
方法:这项多中心试验随机652名孕妇妊娠失败的妇女(厌食症妊娠,胎儿灭绝,不完全和不可避免的自发流产)以1:3的比例接受真空吸入(VA,护理标准)或800 Ig阴道默Misoprostol。接受米索前列醇的受试者在第3天返回。如果POC的驱逐不完整,则给出了800次Ig阴道米索前列醇的第二剂。在第8天,如果驱逐出境仍然不完整,则提供了VA。在第15天,所有受试者都返回进行后续访问。在第30天进行了电话访谈。在初次治疗后30天内,由于任何原因而将失败定义为VA(米索前列醇治疗组)或重新访问(对于VA组)。该研究有动力测试米索前列醇组的成功率是否低于VA组的成功率。如果两组之间的成功率差异不超过18%,则将视为等效。
结果:总体而言,分别为491名和161名女性,随机分配给医学或外科管理。两组的基线特征是可比的。在米索前列醇组中,有71%的妇女在第3天到第8天都完全被驱逐出境。总体而言,VA组的3%发生了治疗失败,米索前列醇组的15%发生(差异= 12%,90%CI 9,16%)。需要住院的出血或子宫内膜炎很少见(<1%),两组之间没有差异。治疗后的紧急医院就诊分别为3.1%和2.0%接受医疗和手术治疗的妇女(p = 0.59)。 78%的妇女会再次选择米索前列醇,如果需要,有83%的妇女向他人推荐。可接受性与VA组中的可接受性没有什么不同。
结论:每个阴道用800 mg米索前列醇治疗早期妊娠衰竭是有效且安全的,成功率约为85%。出血和子宫内膜炎的风险非常低,并且副作用是可以忍受的。这是对大多数参与者的可接受治疗方法。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Small-for-gestational-age infants and risk of fetal death in subsequent pregnancies.
小于胎龄儿和随后妊娠中胎儿死亡的风险。
- DOI:10.1056/nejmp038245
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Zhang,Jun;Klebanoff,MarkA
- 通讯作者:Klebanoff,MarkA
Hormone pattern after misoprostol administration for a nonviable first-trimester gestation.
妊娠早期无法存活的米索前列醇给药后的激素模式。
- DOI:10.1016/j.fertnstert.2003.08.041
- 发表时间:2004
- 期刊:
- 影响因子:6.7
- 作者:Barnhart,KurtT;Bader,Thomas;Huang,Xiangke;Frederick,MargaretM;Timbers,KellyA;Zhang,JunJim
- 通讯作者:Zhang,JunJim
The effect of early epidural versus early intravenous analgesia use on labor progression: a natural experiment.
早期硬膜外镇痛与早期静脉镇痛对分娩进展的影响:一项自然实验。
- DOI:10.1016/j.ajog.2003.11.021
- 发表时间:2004
- 期刊:
- 影响因子:9.8
- 作者:Vahratian,Anjel;Zhang,Jun;Hasling,Jill;Troendle,JamesF;Klebanoff,MarkA;ThorpJr,JohnM
- 通讯作者:ThorpJr,JohnM
Delayed interval delivery and infant survival: a population-based study.
延迟间隔分娩和婴儿存活率:一项基于人群的研究。
- DOI:10.1016/j.ajog.2004.03.002
- 发表时间:2004
- 期刊:
- 影响因子:9.8
- 作者:Zhang,Jun;Hamilton,Brady;Martin,Joyce;Trumble,Ann
- 通讯作者:Trumble,Ann
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIM ZHANG其他文献
JIM ZHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIM ZHANG', 18)}}的其他基金
Duration Of Labor/cesarean Delivery With Epidural Analge
硬膜外镇痛分娩/剖腹产持续时间
- 批准号:
6671919 - 财政年份:
- 资助金额:
-- - 项目类别:
NULLIPARA LABOR AND CESAREAN DELIVERY WITH EPIDURAL ANALGESIA
硬膜外镇痛的无产妇分娩和剖腹产
- 批准号:
6108147 - 财政年份:
- 资助金额:
-- - 项目类别:
Duration Of Labor/Cesarean Delivery With Epidural Analge
硬膜外镇痛分娩/剖腹产持续时间
- 批准号:
6541323 - 财政年份:
- 资助金额:
-- - 项目类别:
Duration of Labor/Cesarean Delivery with Epidural Analgesia in Nullipara
Nullipara 硬膜外镇痛分娩/剖腹产的持续时间
- 批准号:
6432608 - 财政年份:
- 资助金额:
-- - 项目类别:
相似国自然基金
老年重症新冠患者体内炎性细胞的特点、免疫致病机制及临床转归的研究
- 批准号:82370019
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
- 批准号:82303776
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MUC5B/Siglec途径对RA-ILD巨噬细胞胞葬的作用机制及临床价值研究
- 批准号:82302605
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AD谱系患者视网膜标记物偶联视觉神经环路的调控机制及其临床应用研究
- 批准号:82371437
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
结外鼻型NK/T细胞淋巴瘤免疫特征分析与临床转化研究
- 批准号:82370199
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
对晚期癌症患者进行有针对性的早期姑息治疗 (STEP2) 进行现场和虚拟症状筛查的随机对照试验
- 批准号:
490098 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Randomized Control Trial of Nitazoxanide for the Treatment of Cryptosporidium Infection in Malnourished Children in Bangladesh
硝唑尼特治疗孟加拉国营养不良儿童隐孢子虫感染的随机对照试验
- 批准号:
10551559 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Examining the multilevel factors on quality of end-of-life care among cancer patients in Puerto Rico
检查影响波多黎各癌症患者临终关怀质量的多层次因素
- 批准号:
10557584 - 财政年份:2023
- 资助金额:
-- - 项目类别: